Dermatological-Neurological Interactions

Neurology and General Medicine

Volumn , Issue , 2008, Pages 217-225

  Wang, Kevin C ^a   Berger, Timothy G ^b  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b UNIVERSITY OF KENTUCKY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 77953275937     PISSN: None     EISSN: None     Source Type: Book    
DOI: 10.1016/B978-044306707-5.50015-8     Document Type: Chapter

References (99)

1. Wallengren J Brachioradial pruritus: a recurrent solar dermopathy. J Am Acad Dermatol 1998, 39:803.
2. Heyl T Brachioradial pruritus. Arch Dermatol 1983, 119:115.
3. Goodkin R, Wingard E, Bernhard JD Brachioradial pruritus: cervical spine disease and neurogenic/neuropathic [corrected] pruritus. J Am Acad Dermatol 2003, 48:521.
4. Kavak A, Dosoglu M Can a spinal cord tumor cause brachioradial pruritus?. J Am Acad Dermatol 2002, 46:437.
5. Cohen AD, Masalha R, Medvedovsky E, et al. Brachioradial pruritus: a symptom of neuropathy. J Am Acad Dermatol 2003, 48:825.
6. Wallengren J, Sundler F Brachioradial pruritus is associated with a reduction in cutaneous innervation that normalizes during the symptom-free remissions. J Am Acad Dermatol 2005, 52:142.
7. Wallengren J, Dahlback K Familial brachioradial pruritus. Br J Dermatol 2005, 153:1016.
8. Armstrong DK, Bingham EA Brachioradial pruritus-an uncommon photodermatosis presenting in a temperate climate. Dermatology 1997, 195:414.
9. Knight TE, Hayashi T Solar (brachioradial) pruritus-response to capsaicin cream. Int J Dermatol 1994, 33:206.
10. Barry R, Rogers S Brachioradial pruritus-an enigmatic entity. Clin Exp Dermatol 2004, 29:637.
11. Bueller HA, Bernhard JD, Dubroff LM Gabapentin treatment for brachioradial pruritus. J Eur Acad Dermatol Venereol 1999, 13:227.
12. Winhoven SM, Coulson IH, Bottomley WW Brachioradial pruritus: response to treatment with gabapentin. Br J Dermatol 2004, 150:786.
13. Kanitakis J Brachioradial pruritus: report of a new case responding to gabapentin. Eur J Dermatol 2006, 16:311.
14. Tait CP, Grigg E, Quirk CJ Brachioradial pruritus and cervical spine manipulation. Australas J Dermatol 1998, 39:168.
15. Rongioletti F Pruritus as presenting sign of cervical rib. Lancet 1992, 339:55.
16. Stellon A Neurogenic pruritus: an unrecognised problem? A retrospective case series of treatment by acupuncture. Acupunct Med 2002, 20:186.
17. Massey EW, Pleet AB Localized pruritus-notalgia paresthetica. Arch Dermatol 1979, 115:982.
18. Raison-Peyron N, Meunier L, Acevedo M, et al. Notalgia paresthetica: clinical, physiopathological and therapeutic aspects: a study of 12 cases. J Eur Acad Dermatol Venereol 1999, 12:215.
19. Pleet AB, Massey EW Notalgia paresthetica. Neurology 1978, 28:1310.
20. Streib EW, Sun SF Notalgia paresthetica owing to compression neuropathy: case presentation including electrodiagnostic studies. Eur Neurol 1981, 20:64.
21. Savk E, Savk O, Bolukbasi O, et al. Notalgia paresthetica: a study on pathogenesis. Int J Dermatol 2000, 39:754.
22. Chabre O, Labat F, Pinel N, et al. Cutaneous lesion associated with multiple endocrine neoplasia type 2A: lichen amyloidosis or notalgia paresthetica?. Henry Ford Hosp Med J 1992, 40:245.
23. Wallengren J Treatment of notalgia paresthetica with topical capsaicin. J Am Acad Dermatol 1991, 24:286.
24. Goulden V, Toomey PJ, Highet AS Successful treatment of notalgia paresthetica with a paravertebral local anesthetic block. J Am Acad Dermatol 1998, 38:114.
25. Eisenberg E, Barmeir E, Bergman R Notalgia paresthetica associated with nerve root impingement. J Am Acad Dermatol 1997, 37:998.
26. Layton AM, Cotterill JA Notalgia paraesthetica-report of three cases and their treatment. Clin Exp Dermatol 1991, 16:197.
27. Weichert GE An approach to the treatment of anogenital pruritus. Dermatol Ther 2004, 17:129.
28. Smith LE, Henrichs D, McCullah RD Prospective studies on the etiology and treatment of pruritus ani. Dis Colon Rectum 1982, 25:358.
29. Daniel GL, Longo WE, Vernava AM Pruritus ani: causes and concerns. Dis Colon Rectum 1994, 37:670.
30. Dasan S, Neill SM, Donaldson DR, et al. Treatment of persistent pruritus ani in a combined colorectal and dermatological clinic. Br J Surg 1999, 86:1337.
31. Harrington CI, Lewis FM, McDonagh AJ, et al. Dermatological causes of pruritus ani. BMJ 1992, 305:955.
32. Hatch ML, Paradis C, Friedman S, et al. Obsessive-compulsive disorder in patients with chronic pruritic conditions: case studies and discussion. J Am Acad Dermatol 1992, 26:549.
33. Sheehan-Dare RA, Henderson MJ, Cotterill JA Anxiety and depression in patients with chronic urticaria and generalized pruritus. Br J Dermatol 1990, 123:769.
34. Cohen AD, Vander T, Medvendovsky E, et al. Neuropathic scrotal pruritus: anogenital pruritus is a symptom of lumbosacral radiculopathy. J Am Acad Dermatol 2005, 52:61.
35. Heard S Pruritus ani. Aust Fam Physician 2004, 33:511.
36. Koo YM, Lee CS Psychotropic agents. Comprehensive Dermatologic Drug Therapy 2001, 402. WB Saunders, Philadelphia. S.E. Wolverton (Ed.).
37. Jorizzo JL, Gatti S, Smith EB Prurigo: a clinical review. J Am Acad Dermatol 1981, 4:723.
38. Rowland Payne CM, Wilkinson JD, McKee PH, et al. Nodular prurigo-a clinicopathological study of 46 patients. Br J Dermatol 1985, 113:431.
39. Lee MR, Shumack S Prurigo nodularis: a review. Australas J Dermatol 2005, 46:211.
40. Matthews SN, Cockerell CJ Prurigo nodularis in HIV-infected individuals. Int J Dermatol 1998, 37:401.
41. Neri S, Raciti C, D'Angelo G, et al. Hyde's prurigo nodularis and chronic HCV hepatitis. J Hepatol 1998, 28:161.
42. Setoyama M, Mizoguchi S, Kanzaki T Prurigo as a clinical prodrome to adult T-cell leukaemia/lymphoma. Br J Dermatol 1998, 138:137.
43. Runne U, Orfanos CE Cutaneous neural proliferation in highly pruritic lesions of chronic prurigo. Arch Dermatol 1977, 113:787.
44. Vaalasti A, Suomalainen H, Rechardt L Calcitonin gene-related peptide immunoreactivity in prurigo nodularis: a comparative study with neurodermatitis circumscripta. Br J Dermatol 1989, 120:619.
45. Abadia Molina F, Burrows NP, Jones RR, et al. Increased sensory neuropeptides in nodular prurigo: a quantitative immunohistochemical analysis. Br J Dermatol 1992, 127:344.
46. Liang Y, Marcusson JA, Jacobi HH, et al. Histamine-containing mast cells and their relationship to NGFr-immunoreactive nerves in prurigo nodularis: a reappraisal. J Cutan Pathol 1998, 25:189.
47. Harris B, Harris K, Penneys NS Demonstration by S-100 protein staining of increased numbers of nerves in the papillary dermis of patients with prurigo nodularis. J Am Acad Dermatol 1992, 26:56.
48. Johansson O, Liang Y, Emtestam L Increased nerve growth factor- and tyrosine kinase A-like immunoreactivities in prurigo nodularis skin-an exploration of the cause of neurohyperplasia. Arch Dermatol Res 2002, 293:614.
49. Accioly-Filho LW, Nogueira A, Ramos-e-Silva M Prurigo nodularis of Hyde: an update. J Eur Acad Dermatol Venereol 2000, 14:75.
50. Waldinger TP, Wong RC, Taylor WB, et al. Cryotherapy improves prurigo nodularis. Arch Dermatol 1984, 120:1598.
51. Tupker RA, Coenraads PJ, van der Meer JB Treatment of prurigo nodularis, chronic prurigo and neurodermatitis circumscripta with topical capsaicin. Acta Derm Venereol 1992, 72:463.
52. Munn SE, Burrows NP, Abadia-Molina F, et al. The effect of topical capsaicin on substance P immunoreactivity: a clinical trial and immunohistochemical analysis. Acta Derm Venereol 1997, 77:158.
53. Stander S, Luger T, Metze D Treatment of prurigo nodularis with topical capsaicin. J Am Acad Dermatol 2001, 44:471.
54. 3 (tacalcitol) for steroid-resistant prurigo. Br J Dermatol 1996, 135:237.
55. Berth-Jones J, Smith SG, Graham-Brown RA Nodular prurigo responds to cyclosporin. Br J Dermatol 1995, 132:795.
56. Divekar PM, Palmer RA, Keefe M Phototherapy in nodular prurigo. Clin Exp Dermatol 2003, 28:99.
57. Herranz P, Pizarro A, De Lucas R, et al. Treatment of AIDS-associated prurigo nodularis with thalidomide. Clin Exp Dermatol 1998, 23:233.
58. Maurer T, Poncelet A, Berger T Thalidomide treatment for prurigo nodularis in human immunodeficiency virus-infected subjects: efficacy and risk of neuropathy. Arch Dermatol 2004, 140:845.
59. van den Broek H Treatment of prurigo nodularis with thalidomide. Arch Dermatol 1980, 116:571.
60. Winkelmann RK, Connolly SM, Doyle JA, et al. Thalidomide treatment of prurigo nodularis. Acta Derm Venereol 1984, 64:412.
61. Grosshans E, Illy G Thalidomide therapy for inflammatory dermatoses. Int J Dermatol 1984, 23:598.
62. Radomsky CL, Levine N Thalidomide. Dermatol Clin 2001, 19:87.
63. Alfadley A, Al-Hawsawi K, Thestrup-Pedersen K, et al. Treatment of prurigo nodularis with thalidomide: a case report and review of the literature. Int J Dermatol 2003, 42:372.
64. Babb RR, Alarcon-Segovia D, Fairbairn JF Erythermalgia: review of 51 cases. Circulation 1964, 29:136.
65. Finley WH, Lindsey JR, Fine JD, et al. Autosomal dominant erythromelalgia. Am J Med Genet 1992, 42:310.
66. Layzer RB Hot feet: erythromelalgia and related disorders. J Child Neurol 2001, 16:199.
67. Cohen JS Erythromelalgia: new theories and new therapies. J Am Acad Dermatol 2000, 43:841.
68. Drenth JP, Michiels JJ, Van Joost T, et al. Verapamil-induced secondary erythermalgia. Br J Dermatol 1992, 127:292.
69. Thami GP, Bhalla M Erythromelalgia induced by possible calcium channel blockade by ciclosporin. BMJ 2003, 326:910.
70. Davis MD, Sandroni P, Rooke TW, et al. Erythromelalgia: vasculopathy, neuropathy, or both? A prospective study of vascular and neurophysiologic studies in erythromelalgia. Arch Dermatol 2003, 139:1337.
71. Drenth JP, te Morsche RH, Guillet G, et al. SCN9A mutations define primary erythermalgia as a neuropathic disorder of voltage gated sodium channels. J Invest Dermatol 2005, 124:1333.
72. Waxman SG, Dib-Hajj S Erythermalgia: molecular basis for an inherited pain syndrome. Trends Mol Med 2005, 11:555.
73. Seishima M, Kanoh H, Izumi T, et al. A refractory case of secondary erythermalgia successfully treated with lumbar sympathetic ganglion block. Br J Dermatol 2000, 143:868.
74. Stricker LJ, Green CR Resolution of refractory symptoms of secondary erythermalgia with intermittent epidural bupivacaine. Reg Anesth Pain Med 2001, 26:488.
75. Burton AW, Bruehl S, Harden RN Current diagnosis and therapy of complex regional pain syndrome: refining diagnostic criteria and therapeutic options. Expert Rev Neurother 2005, 5:643.
76. Berlin AL, Pehr K Coexistence of erythromelalgia and Raynaud's phenomenon. J Am Acad Dermatol 2004, 50:456.
77. Ljubojevic S, Lipozencic J, Pustisek N Erythromelalgia. Acta Dermatovenerol Croat 2004, 12:99.
78. Birklein F Complex regional pain syndrome. J Neurol 2005, 252:131.
79. Ramelet AA Rosacea: a reaction pattern associated with ocular lesions and migraine?. Arch Dermatol 1994, 130:1448.
80. Wilkin JK Rosacea: pathophysiology and treatment. Arch Dermatol 1994, 130:359.
81. Wollina U The response of erythematous rosacea to ondansetron. Br J Dermatol 1999, 140:561.
82. Marks R Histogenesis of the inflammatory component of rosacea. Proc R Soc Med 1973, 66:742.
83. Tan SG, Cunliffe WJ Rosacea and migraine. BMJ 1976, 1:21.
84. Berg M Facial skin complaints and work at visual display units: epidemiological, clinical and histopathological studies. Acta Derm Venereol Suppl (Stockh) 1989, 150:1.
85. Berg M, Liden S Postmenopausal female rosacea patients are more disposed to react with migraine. Dermatology 1996, 193:73.
86. Craige H, Cohen JB Symptomatic treatment of idiopathic and rosacea-associated cutaneous flushing with propranolol. J Am Acad Dermatol 2005, 53:881.
87. Wiffen PJ, McQuay HJ, Edwards JE, et al. Gabapentin for acute and chronic pain. Cochrane Database Syst Rev 2005, CD005452.
88. Sato K, Kang WH, Saga K, et al. Biology of sweat glands and their disorders. Part 2. Disorders of sweat gland function. J Am Acad Dermatol 1989, 20:713.
89. Wenzel FG, Horn TD Nonneoplastic disorders of the eccrine glands. J Am Acad Dermatol 1998, 38:1.
90. Thami GP, Kaur S, Kanwar AJ Acquired idiopathic generalized anhidrosis: a rare cause of heat intolerance. Clin Exp Dermatol 2003, 28:262.
91. Itakura E, Urabe K, Yasumoto S, et al. Cholinergic urticaria associated with acquired generalized hypohidrosis: report of a case and review of the literature. Br J Dermatol 2000, 143:1064.
92. Tsuji T, Yamamoto T Acquired generalized anhidrosis. Arch Dermatol 1976, 112:1310.
93. Murakami K, Sobue G, Terao S, et al. Acquired idiopathic generalized anhidrosis: a distinctive clinical syndrome. J Neurol 1988, 235:428.
94. Terui T, Ohkawa Y, Tagami H Idiopathic acquired generalized anhidrosis: electron-microscopic and immunohistochemical studies and analysis of lectin-binding pattern of the cell membrane. Dermatologica 1989, 178:123.
95. Miyazoe S, Matsuo H, Ohnishi A, et al. Acquired idiopathic generalized anhidrosis with isolated sudomotor neuropathy. Ann Neurol 1998, 44:378.
96. Dice JP Physical urticaria. Immunol Allergy Clin North Am 2004, 24:225.
97. Mahmood T Physical urticarias. Am Fam Physician 1994, 49:1411.
98. Soter NA, Wasserman SI, Austen KF, et al. Release of mast-cell mediators and alterations in lung function in patients with cholinergic urticaria. N Engl J Med 1980, 302:604.
99. Ando Y, Fujii S, Sakashita N, et al. Acquired idiopathic generalized anhidrosis: clinical manifestations and histochemical studies. J Neurol Sci 1995, 132:80.